Govender, Radha; De Greef, Jacques; Delport, Rhena; Becker, Piet J.; Vermaak, William J.H.(Clinics Cardiv, 2008-05)
AIM: Ischaemia-modified albumin (IMA), as measured by the albumin-cobalt binding (ACB) test®, has been cleared by the US Food and Drug administration as a biomarker to exclude the presence of myocardial ischaemia in patients. ...
De Greef, Jacques; Govender, Radha; Vermaak, William J.H.; Perumal, Nalini S.; Libhaber, Elena; Vangu, Mboyo-Di-Tamba(Clinics Cardiv, 2007-11)
BACKGROUND: B-type natriuretic peptide(BNP) and the inactive amino-terminal pro-B-type natriuretic peptide (NT-proBNP) have a prognostic value in heart failure and in myocardial infarction. There has been some evidence ...
Vermaak, William J.H.(Health and Medical Publishing Group, 2003-07)
The older 'traditional' lipid guidelines have placed undue emphasis on individually high-risk factors such as cholesterol. The aim of the TC cut-off points of 5.2 mmol/l and 6.2 mmol/l was to identify as many subjects as ...
De Greef, Jacques; Funk, Maryke; Vermaak, William J.H.; Perumal, Nalini S.; Libhaber, Carlos D.; Vangu, Mboyo-Di-Tamba(Clinics Cardiv, 2008-09)
BACKROUND: Amino terminal pro-B-type natriuretic peptide (NT-proBNP) is a sensitive marker of ventricular dysfunction. Exercise causes an increase in the secretion of NT-proBNP, and with myocardial ischaemia the increase ...
Duse, A.G.; Morar, A.; Landman, I.; Vermaak, William J.H.; Schoeman, H.; Kruger, M.J.; Janse van Rensburg, E.S. (Elsie); Luthy, R.; Singh, S.(Health and Medical Publishing Group, 2008)
OBJECTIVES. To assess the effectiveness and safety of a twice-daily regimen of a generic fixed-dose combination
(FDC) of stavudine, lamivudine and nevirapine (Triviro) in a cohort of Zimbabwean HIV-1-positive adults.
DESIGN: ...
